Flavorings in tobacco products induce endothelial cell dysfunction

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 38, Issue 7, 2018, Pages 1607-1615

  Fetterman, Jessica L ^a   Weisbrod, Robert M ^a   Feng, Bihua ^a   Bastin, Reena ^a   Tuttle, Shawn T ^a   Holbrook, Monica ^a   Baker, Gregory ^a   Robertson, Rose Marie ^c   Conklin, Daniel J ^b   Bhatnagar, Aruni ^c   Hamburg, Naomi M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Louisville School of Medicine   (United States)

^c AMERICAN HEART ASSOCIATION   (United States)

Author keywords

endothelial cells; eugenol; inflammation; nitric oxide; tobacco

Indexed keywords

2,3 BUTANEDIONE; 2,5 DIMETHYLPYRAZINE; ACETYLPYRAZINE; ANTIMYCIN A1; CALCIMYCIN; CINEOLE; CINNAMALDEHYDE; DIMETHYLPYRAZINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EUGENOL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; ISOPENTYL ACETATE; MENTHOL; NITRIC OXIDE; PYRAZINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; TOBACCO SMOKE; UNCLASSIFIED DRUG; VANILLIN; AUTACOID; FLAVORING AGENT; IL6 PROTEIN, HUMAN; NOS3 PROTEIN, HUMAN;

ADULT; AORTIC ENDOTHELIAL CELL; ARTICLE; CELL DEATH; CELL FUNCTION; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; FLAVOR; FLOW-MEDIATED DILATION TEST; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; NONSMOKER; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TOBACCO; VASCULAR ENDOTHELIAL CELL; VASODILATATION; CASE CONTROL STUDY; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; ELECTRONIC CIGARETTE; ENDOTHELIUM CELL; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK ASSESSMENT; SMOKING; TOXICITY; VAPING;

ADULT; CASE-CONTROL STUDIES; CELL DEATH; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRONIC NICOTINE DELIVERY SYSTEMS; ENDOTHELIAL CELLS; FEMALE; FLAVORING AGENTS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RISK ASSESSMENT; SMOKING; TOBACCO PRODUCTS; VAPING;

EID: 85056447902     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.118.311156     Document Type: Article

References (40)

1. Bhatnagar A. Cardiovascular perspective of the promises and perils of e-cigarettes. Circ Res. 2016; 118: 1872-1875. doi: 10. 1161/CIRCRESAHA. 116. 308723.
2. Green SH, Bayer R, Fairchild AL. Evidence, policy, and e-cigarettes-will England reframe the debate N Engl J Med. 2016; 374: 1301-1303. doi: 10. 1056/NEJMp1601154.
3. Fairchild AL, Lee JS, Bayer R, Curran J. E-cigarettes and the harmreduction continuum. N Engl J Med. 2018; 378: 216-219. doi: 10. 1056/NEJMp1711991.
4. Singh T, Arrazola RA, Corey CG, Husten CG, Neff LJ, Homa DM, King BA. Tobacco use among middle and high school students-United States, 2011-2015. MMWR Morb Mortal Wkly Rep. 2016; 65: 361-367. doi: 10. 15585/mmwr. mm6514a1.
5. Neff LJ, Arrazola RA, Caraballo RS, Corey CG, Cox S, King BA, Choiniere CJ, Husten CG. Frequency of tobacco use among middle and high school students-United States, 2014. MMWR Morb Mortal Wkly Rep. 2015; 64: 1061-1065. doi: 10. 15585/mmwr. mm6438a1.
6. Barrington-Trimis JL, Urman R, Berhane K, Unger JB, Cruz TB, Pentz MA, Samet JM, Leventhal AM, McConnell R. E-cigarettes and future cigarette use. Pediatrics. 2016; 138: e20160379.
7. Barrington-Trimis JL, Urman R, Leventhal AM, Gauderman WJ, Cruz TB, Gilreath TD, Howland S, Unger JB, Berhane K, Samet JM, McConnell R. E-cigarettes, cigarettes, and the prevalence of adolescent tobacco use. Pediatrics. 2016; 138: e20153983.
8. Leventhal AM, Strong DR, Kirkpatrick MG, Unger JB, Sussman S, Riggs NR, Stone MD, Khoddam R, Samet JM, Audrain-McGovern J. Association of electronic cigarette use with initiation of combustible tobacco product smoking in early adolescence. JAMA. 2015; 314: 700-707. doi: 10. 1001/jama. 2015. 8950.
9. Berg CJ. Preferred flavors and reasons for e-cigarette use and discontinued use among never, current, and former smokers. Int J Public Health. 2016; 61: 225-236. doi: 10. 1007/s00038-015-0764-x.
10. Corey CG, Ambrose BK, Apelberg BJ, King BA. Flavored tobacco product use among middle and high school students-United States, 2014. MMWR Morb Mortal Wkly Rep. 2015; 64: 1066-1070. doi: 10. 15585/mmwr. mm6438a2.
11. Goldenson NI, Kirkpatrick MG, Barrington-Trimis JL, Pang RD, McBeth JF, Pentz MA, Samet JM, Leventhal AM. Effects of sweet flavorings and nicotine on the appeal and sensory properties of e-cigarettes among young adult vapers: application of a novel methodology. Drug Alcohol Depend. 2016; 168: 176-180. doi: 10. 1016/j. drugalcdep. 2016. 09. 014.
12. Kostygina G, Ling PM. Tobacco industry use of flavourings to promote smokeless tobacco products. Tob Control. 2016; 25 (suppl 2): ii40-ii49. doi: 10. 1136/tobaccocontrol-2016-053212.
13. Kostygina G, Glantz SA, Ling PM. Tobacco industry use of flavours to recruit new users of little cigars and cigarillos. Tob Control. 2016; 25: 66-74. doi: 10. 1136/tobaccocontrol-2014-051830.
14. Ambrose BK, Day HR, Rostron B, Conway KP, Borek N, Hyland A, Villanti AC. Flavored tobacco product use among US youth aged 12-17 years, 2013-2014. JAMA. 2015; 314: 1871-1873. doi: 10. 1001/jama. 2015. 13802.
15. Delnevo CD, Giovenco DP, Ambrose BK, Corey CG, Conway KP. Preference for flavoured cigar brands among youth, young adults and adults in the USA. Tob Control. 2015; 24: 389-394. doi: 10. 1136/tobaccocontrol-2013-051408.
16. McEvoy JW, Nasir K, DeFilippis AP, Lima JA, Bluemke DA, Hundley WG, Barr RG, Budoff MJ, Szklo M, Navas-Acien A, Polak JF, Blumenthal RS, Post WS, Blaha MJ. Relationship of cigarette smoking with inflammation and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2015; 35: 1002-1010. doi: 10. 1161/ATVBAHA. 114. 304960.
17. Powell JT. Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med. 1998; 3: 21-28. doi: 10. 1177/1358836X9800300105.
18. Messner B, Bernhard D. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol. 2014; 34: 509-515. doi: 10. 1161/ATVBAHA. 113. 300156.
19. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003; 42: 1149-1160.
20. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, Vita JA. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol. 2003; 41: 1769-1775.
21. O'Toole TE, Abplanalp W, Li X, Cooper N, Conklin DJ, Haberzettl P, Bhatnagar A. Acrolein decreases endothelial cell migration and insulin sensitivity through induction of let-7a. Toxicol Sci. 2014; 140: 271-282. doi: 10. 1093/toxsci/kfu087.
22. DeJarnett N, Conklin DJ, Riggs DW, et al. Acrolein exposure is associated with increased cardiovascular disease risk. J Am Heart Assoc. 2014; 3: e000934.
23. Haberzettl P, Vladykovskaya E, Srivastava S, Bhatnagar A. Role of endoplasmic reticulum stress in acrolein-induced endothelial activation. Toxicol Appl Pharmacol. 2009; 234: 14-24. doi: 10. 1016/j. Taap. 2008. 09. 019.
24. Carnevale R, Sciarretta S, Violi F, Nocella C, Loffredo L, Perri L, Peruzzi M, Marullo AG, De Falco E, Chimenti I, Valenti V, Biondi-Zoccai G, Frati G. Acute impact of tobacco vs electronic cigarette smoking on oxidative stress and vascular function. Chest. 2016; 150: 606-612. doi: 10. 1016/j. chest. 2016. 04. 012.
25. McMackin CJ, Vita JA. Update on nitric oxide-dependent vasodilation in human subjects. Methods Enzymol. 2005; 396: 541-553. doi: 10. 1016/S0076-6879 (05)96046-1.
26. Shenouda SM, Widlansky ME, Chen K, et al. Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation. 2011; 124: 444-453. doi: 10. 1161/CIRCULATIONAHA. 110. 014506.
27. Tabit CE, Shenouda SM, Holbrook M, Fetterman JL, Kiani S, Frame AA, Kluge MA, Held A, Dohadwala MM, Gokce N, Farb MG, Rosenzweig J, Ruderman N, Vita JA, Hamburg NM. Protein kinase C-contributes to impaired endothelial insulin signaling in humans with diabetes mellitus. Circulation. 2013; 127: 86-95. doi: 10. 1161/CIRCULATIONAHA. 112. 127514.
28. Fetterman JL, Holbrook M, Flint N, Feng B, Bretón-Romero R, Linder EA, Berk BD, Duess MA, Farb MG, Gokce N, Shirihai OS, Hamburg NM, Vita JA. Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling. Atherosclerosis. 2016; 247: 207-217. doi: 10. 1016/j. atherosclerosis. 2016. 01. 043.
29. Vita JA, Keaney JF Jr. Endothelial function: a barometer for cardiovascular risk Circulation. 2002; 106: 640-642.
30. Vozoris NT. Mentholated cigarettes and cardiovascular and pulmonary diseases: a population-based study. Arch Intern Med. 2012; 172: 590-591. doi: 10. 1001/archinternmed. 2012. 320.
31. Jones MR, Tellez-Plaza M, Navas-Acien A. Smoking, menthol cigarettes and all-cause, cancer and cardiovascular mortality: evidence from the National Health and Nutrition Examination Survey (NHANES) and a metaanalysis. PLoS One. 2013; 8: e77941. doi: 10. 1371/journal. pone. 0077941.
32. Munro HM, Tarone RE, Wang TJ, Blot WJ. Menthol and nonmenthol cigarette smoking: all-cause deaths, cardiovascular disease deaths, and other causes of death among blacks and whites. Circulation. 2016; 133: 1861-1866. doi: 10. 1161/CIRCULATIONAHA. 115. 020536.
33. Park SJ, Foreman MG, Demeo DL, Bhatt SP, Hansel NN, Wise RA, Soler X, Bowler RP. Menthol cigarette smoking in the COPDGene cohort: relationship with COPD, comorbidities and CT metrics. Respirology. 2015; 20: 108-114. doi: 10. 1111/resp. 12421.
34. Pletcher MJ, Hulley BJ, Houston T, Kiefe CI, Benowitz N, Sidney S. Menthol cigarettes, smoking cessation, atherosclerosis, and pulmonary function: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arch Intern Med. 2006; 166: 1915-1922. doi: 10. 1001/archinte. 166. 17. 1915.
35. Putzhammer R, Doppler C, Jakschitz T, Heinz K, Förste J, Danzl K, Messner B, Bernhard D. Vapours of US and EU market leader electronic cigarette brands and liquids are cytotoxic for human vascular endothelial cells. PLoS One. 2016; 11: e0157337. doi: 10. 1371/journal. pone. 0157337.
36. Schweitzer KS, Chen SX, Law S, et al. Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures. Am J Physiol Lung Cell Mol Physiol. 2015; 309: L175-L187. doi: 10. 1152/ajplung. 00411. 2014.
37. Puranik R, Celermajer DS. Smoking and endothelial function. Prog Cardiovasc Dis. 2003; 45: 443-458. doi: 10. 1053/pcad. 2003. YPCAD13.
38. Vita JA. Endothelial function. Circulation. 2011; 124: e906-e912. doi: 10. 1161/CIRCULATIONAHA. 111. 078824.
39. Pankow JF, Kim K, McWhirter KJ, Luo W, Escobedo JO, Strongin RM, Duell AK, Peyton DH. Benzene formation in electronic cigarettes. PLoS One. 2017; 12: e0173055. doi: 10. 1371/journal. pone. 0173055.
40. Benowitz NL, Herrera B, Jacob P 3rd. Mentholated cigarette smoking inhibits nicotine metabolism. J Pharmacol Exp Ther. 2004; 310: 1208-1215. doi: 10. 1124/jpet. 104. 066902.